Cytokinetics

CND Life Sciences’ Syn-One® Biomarker Services Advance Parkinson’s Research in Phase 2 Clinical Trial

PHOENIX, AZ – November 11, 2025 — CND Life Sciences, a pioneering neurodiagnostic company, announced that its Syn-One® Biomarker...

By cGxPwire Editor
November 11, 2025

Bio-Pharma

Cytokinetics Presents New MAPLE-HCM Data at AHA 2025, Strengthening Pipeline in Rare Cardiomyopathy Therapy

San Francisco, November 10, 2025 — Cytokinetics, Inc., a biopharmaceutical company focused on developing muscle biology–driven therapies, announced the...

By cGxPwire Editor
November 10, 2025

We work Hard to get you posted with latest updates

Unwrap our new Directory

Cytokinetics

CND Life Sciences’ Syn-One® Biomarker Services Advance Parkinson’s Research in Phase 2 Clinical Trial

Cytokinetics Presents New MAPLE-HCM Data at AHA 2025, Strengthening Pipeline in Rare Cardiomyopathy Therapy